Newcomer, J. W., Tocco, M., Pikalov, A., Zheng, H., Cucchiaro, J., & Loebel, A. (2016). PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone. Int J Neuropsychopharmacol.
Styl ChicagoNewcomer, John W., Michael Tocco, Andrei Pikalov, Hanzhe Zheng, Josephine Cucchiaro, a Antony Loebel. "PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone." Int J Neuropsychopharmacol 2016.
Citace podle MLANewcomer, John W., et al. "PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone." Int J Neuropsychopharmacol 2016.